Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialVedang Murthy, Umesh Mahantshetty, Priyamvada Maitre et al.|Journal of Clinical Oncology|2021Cited by 338
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Anthony J. Gill, Ondřej Hes et al.|Modern Pathology|2021Cited by 254
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Ondřej Hes, Mahul B. Amin et al.|Modern Pathology|2021Cited by 222
<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinomaJoão Lobo, Holger Moch, Riuko Ohashi et al.|Histopathology|2022Cited by 112
Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trialVedang Murthy, Umesh Mahantshetty, Priyamvada Maitre et al.|Radiotherapy and Oncology|2020Cited by 70